cBioPortal Proxy Endpoint Vulnerabliity
21Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 8.3epss 0.6%
exploitation probability
0.6%top 54% of all CVEs
observed exploitation
nono source reports it
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L
Affected products
cBioPortal · cbioportalReferences
https://github.com/cBioPortal/cbioportal/commit/ea8642fdbda2d61d2ab34b9da7a1594680bbbcd5https://github.com/cBioPortal/cbioportal/pull/10884https://github.com/cBioPortal/cbioportal/releases/tag/v6.0.12https://github.com/cBioPortal/cbioportal/security/advisories/GHSA-9h44-r3c3-q7rmhttps://www.wizlynxgroup.com/security-research-advisories/vuln/WLX-2024-004